Alejandro Martín García-Sancho

Featured in: Favicon

nature.com Favicon

onlinelibrary.wiley.com

Articles

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma | Blood Cancer Journal

Nov 6, 2024 | nature.com | Adam S. Kittai |Antonio Gutierrez |Antonio Gutiérrez |Alejandro Martín García-Sancho |Monica D. Mead |Pere Barba | +2 more

The rationale for this project arises from some considerations. Clinical trials often use surrogate endpoints (response rates) rather than direct measurement of benefit (survivals) as primary objective of the study.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →